Cluster of differentiation 20, also B-lymphocyte antigen, is expressed from the pre-B stage to terminal cellular differentiation.
It is the target of rituximab.
Cluster of differentiation 20, also B-lymphocyte antigen, is expressed from the pre-B stage to terminal cellular differentiation.
It is the target of rituximab.